μ-Opioid Receptor Is Induced by IL-13 within Lymph Nodes from Patients with Sézary Syndrome
- 1 May 2010
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 130 (5), 1337-1344
- https://doi.org/10.1038/jid.2009.433
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Opioids and the skin – where do we stand?Experimental Dermatology, 2009
- Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cellsJournal of Neuroimmunology, 2008
- T-Cell Receptor/CD28-Mediated Activation of Human T Lymphocytes Induces Expression of Functional μ-Opioid ReceptorsMolecular Pharmacology, 2008
- Opioid receptor blockade reduces Fas-induced hepatitis in miceJournal of Hepatology, 2004
- IL-13 receptors and signaling pathways: An evolving webJournal of Allergy and Clinical Immunology, 2003
- Diminished responses to IL-13 by human monocytes differentiatedin vitro: role of the IL-13Rα1 chain and STAT6European Journal of Immunology, 1999
- The distribution of IL-13 receptor α1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4European Journal of Immunology, 1998
- Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor geneProceedings of the National Academy of Sciences of the United States of America, 1998
- Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans CellsThe Journal of Experimental Medicine, 1998
- Identification of κ‐ and δ‐opioid receptor transcripts in immune cellsFEBS Letters, 1995